Kampf A, Barfknecht R L, Shaffer P J, Osaki S, Mertes M P
J Med Chem. 1976 Jul;19(7):903-8. doi: 10.1021/jm00229a009.
In a study of active site binding the inhibition of thymidylate synthetase derived from Escherichia coli, calf thymus, and Ehrlich ascites tumor was examined using eight inhibitors. 5-Substituted 2'-deoxyuridine 5'-phosphate analogues used in this study are the hydroxymethyl, methoxymethyl, benzyloxymethyl, formyl, acetyl, allyl, and two potential active site alkylating substituents: 2,3-oxypropyl and the azidomethyl analogues. All compounds were competitive with the substrate, 2'-deoxyuridine 5'-phosphate; the most potent inhibitor was 5-formyl-dUMP (Ki = 0.1, 0.09, and 0.08 muM for the respective enzyme). The 5-hydroxymethyl, 5-benzyloxymethyl, and 5-azidomethyl derivatives of dUMP showed some differential inhibition; these compounds were two to three times more active against the ascites tumor enzyme than against the thymus enzyme.
在一项关于活性位点结合的研究中,使用8种抑制剂检测了源自大肠杆菌、小牛胸腺和艾氏腹水瘤的胸苷酸合成酶的抑制作用。本研究中使用的5-取代2'-脱氧尿苷5'-磷酸类似物有羟甲基、甲氧基甲基、苄氧基甲基、甲酰基、乙酰基、烯丙基以及两个潜在的活性位点烷基化取代基:2,3-氧丙基和叠氮甲基类似物。所有化合物均与底物2'-脱氧尿苷5'-磷酸竞争;最有效的抑制剂是5-甲酰基-dUMP(对相应酶的Ki分别为0.1、0.09和0.08μM)。dUMP的5-羟甲基、5-苄氧基甲基和5-叠氮甲基衍生物表现出一些差异抑制作用;这些化合物对腹水瘤酶的活性比对胸腺酶的活性高两到三倍。